Skip to main content
    P

    Palisade Bio Inc (PALI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.03
    -0.09 (-8.04%)

    Market Cap: $201.01M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Palisade Bio Inc (PALI) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Palisade Bio are SAB Biotherapeutics (SABS), Precision BioSciences (DTIL) and Upstream Bio (UPB). By market cap, Palisade Bio ranks 9th of the 13 companies on this page; Nautilus Biotechnology (NAUT) is the largest at $295.50M.

    Peer Comparison

    PALI's revenue growth of 0.0% is above the peer median of -3.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Palisade Bio (PALI)$201.01MN/A436.8x0.0%N/A0.0%0.00%
    SAB Biotherapeutics Inc (SABS)$266.66MN/AN/A0.0%N/A-62.4%0.00%
    Precision BioSciences Inc (DTIL)$288.76MN/A4.4x-85.6%-38.3%37272.0%0.00%
    Upstream Bio, Inc. (UPB)$152.38MN/A41.0x0.0%N/A-42.2%0.00%
    Greenwich Lifesciences Inc (GLSI)$219.29MN/AN/A0.0%N/A0.0%0.00%
    Bright Minds Biosciences Inc (DRUG)$227.96MN/AN/A0.0%-11.2%0.0%0.00%
    Sutro Biopharma (STRO)$163.03MN/A3.4x0.0%N/A-6.1%0.00%
    Nautilus Biotechnology Inc (NAUT)$295.50MN/A630.2x0.0%N/A0.0%0.00%
    Korro Bio, Inc. (KRRO)$186.81MN/A175.8x0.0%-82.8%-43.1%0.00%
    Lineage Cell Therapeutics Inc (LCTX)$231.35MN/A18.7x16.2%-6.7%-61.0%0.00%
    Q32 Bio Inc (QTTB)$260.64M2.5x5.2x60.0%N/A0.0%0.00%
    Sol Gel Technologies Ltd (SLGL)$180.46MN/A125.4x0.0%N/A-96.6%0.00%
    Bicycle Therapeutics Ltd (BCYC)$236.22MN/A2.7x-169.8%N/A190.2%0.00%
    Peer median$229.66M2.5x18.7x0.0%-24.7%-3.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Palisade Bio, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    SAB Biotherapeutics Inc (SABS)
    SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology.
    SABS competitors
    Precision BioSciences Inc (DTIL)
    Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States.
    DTIL competitors
    Upstream Bio, Inc. (UPB)
    Upstream Bio, Inc., a clinical-stage biotechnology company, develops treatments for inflammatory diseases that focuses on severe respiratory disorders.
    UPB competitors
    Greenwich Lifesciences Inc (GLSI)
    Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for breast and other HER2 /...
    GLSI competitors
    Bright Minds Biosciences Inc (DRUG)
    Bright Minds Biosciences Inc. (DRUG) is a forward-thinking clinical-stage biotechnology firm specializing in the development of groundbreaking therapies...
    DRUG competitors
    Sutro Biopharma (STRO)
    Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company.
    STRO competitors
    Nautilus Biotechnology Inc (NAUT)
    Nautilus Biotechnology, Inc., a development-stage life sciences company, is dedicated to creating platform technology to quantify and unlock proteome...
    NAUT competitors
    Korro Bio, Inc. (KRRO)
    Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare...
    KRRO competitors
    Lineage Cell Therapeutics Inc (LCTX)
    Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapeutics for the treatment...
    LCTX competitors
    Q32 Bio Inc (QTTB)
    Q32 Bio Inc. (QTTB) is a pioneering biotechnology firm focused on the development of advanced antibody-based therapies for autoimmune diseases and immune...
    QTTB competitors
    Sol Gel Technologies Ltd (SLGL)
    Sol-Gel Technologies Ltd., a specialty clinical-stage pharmaceutical company, is focused on developing and commercializing topical dermatological...
    SLGL competitors
    Bicycle Therapeutics Ltd (BCYC)
    Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, is developing a class of drugs for diseases that are not served by existing treatments.
    BCYC competitors

    Frequently Asked Questions About PALI

    Who are Palisade Bio's main competitors?

    The companies most similar to Palisade Bio include SAB Biotherapeutics (SABS), Precision BioSciences (DTIL), Upstream Bio (UPB), Greenwich Lifesciences (GLSI) and Bright Minds Biosciences (DRUG), listed from the closest match.

    Who is Palisade Bio's biggest competitor?

    Nautilus Biotechnology (NAUT) is the largest of the similar companies at $295.50M; SAB Biotherapeutics (SABS) is the closest match by business profile, size, sector and industry.

    How does PALI stock compare with its competitors?

    PALI's P/S is 436.8x against a peer median of 18.7x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Palisade Bio's competitors pays a higher dividend?

    Palisade Bio pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Palisade Bio bigger than its competitors?

    No. Palisade Bio is 9th by market cap among the 13 companies on this page; the largest is Nautilus Biotechnology (NAUT) at $295.50M.